Bank Capital Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bank Capital Indonesia Tbk trades at Rp101 (market cap 2.03T, 1.66M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Bank Capital Indonesia Tbk is far larger — about 6.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Bank Capital Indonesia Tbk is more actively traded (1.66M versus 159.2K). Which is the better fit depends on your goals.
| BACA | DGNS | |
|---|---|---|
Market Cap | 2.03T | 310.75B |
Volume | 1.66M | 159.2K |
Lot | 16.61K | 1.59K |
Turnover | 166.37M | 34.72M |
Average Price | 100.17 | 218.06 |
Value | 166.37M | 34.72M |
Indicative Equilibrium Price | 101 | 220 |
Indicative Equilibrium Volume | 20 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Capital Indonesia (the company) was established under its original name of PT Bank Credit Lyonnais base on notarial deed No.139 of Mrs Siti Pertiwi, S.H, dated on Apr 20, 1989. The Company's articles of association has been amended several times, most recently by notarial deed No. 60 of Eliwati Tjitra, S.H., dated Jul 17, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering.
Read more on BACA →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →